Pharma 'could have done a better job' explaining drug costs
Bourla, A.; Johnson, S.R.
Modern Healthcare 45(50): 30-31
2015
ISSN/ISBN: 0160-7480 PMID: 26875328 Document Number: 685266
Document emailed within 1 workday
Related Documents
Kulbertus, H. 1999: Pharma-clinics. The drug of the month. Candesartan (Atacand) Revue Medicale de Liege 54(6): 557-560Scheen, A.J. 1996: Pharma-clinics. Drug of the month. Tacrine (Cognex) Revue Medicale de Liege 51(5): 379-381
Scheen, A.J. 2000: Pharma-clinics. The drug of the month. Rofecoxib (Vioxx) Revue Medicale de Liege 55(7): 751-753
2012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Piérard, G.E. 1997: Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne Revue Medicale de Liege 52(2): 120-122
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Andreasen, J. 2003: Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities Ugeskrift for laeger 165(29): 2873-2876
Andersen, V. 1993: Drug costs Ugeskrift for Laeger 155(42): 3398-3399
Lexchin, J. 1989: Reducing drug costs New Zealand Medical Journal 102(872): 387
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Schwartz, H. 1981: Medical costs and the drug industry Medical Times 109(3): 21s-24s; 28s
Von Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808
2010: Alzheimer's drug costs likely to rise as boomers age Managed Care 19(11): 43
Rico, M.J. 2000: Rising drug costs: the impact on dermatology Skin Therapy Letter 5(4): 1-2,5
Rico, M.J. 2000: Rising drug costs: the impact on dermatology Skin Therapy Letter 5(4): 1-2,5
Halpern, G.A. 1989: Evaluating the real costs of drug therapy American Journal of Hospital Pharmacy 46(12): 2460-2461
Davern, P.F.; Kubica, A.J. 1984: Controlling drug costs: administrative and clinical strategies Topics in Hospital Pharmacy Management 3(4): 49-59
McGregor, M. 1998: Coverage of drug costs: reference-based pricing Canadian Journal of Cardiology 14(5): 666-668
Kappeler, K.H.; Birdwell, S.W.; Scheckelhoff, D.J.; Reilly, C.H. 1992: Model for evaluating costs associated with I.v. drug delivery systems American Journal of Hospital Pharmacy 49(6): 1478-1481